Home/Filings/4/0001209191-19-035510
4//SEC Filing

Reiter Sarah 4

Accession 0001209191-19-035510

CIK 0001469443other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:05 PM ET

Size

9.6 KB

Accession

0001209191-19-035510

Insider Transaction Report

Form 4
Period: 2019-06-03
Reiter Sarah
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-06-03+23,30571,705 total
    Exercise: $5.04Exp: 2029-06-03Common Stock (23,305 underlying)
Footnotes (1)
  • [F1]The Option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or June 3, 2020, with the remaining 75% vesting in 36 equal installments beginning June 30, 2020 and ending May 31, 2023, subject to the Participant's continued service.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0001734605

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:05 PM ET
Size
9.6 KB